← Open Payments lookup

BELA LASCHIVER: Open Payments

NPI 1497896286 · LIVINGSTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,037 in 72 payments from 16 companies in 2025. Trend: 2023 $1,980 · 2024 $2,065 · 2025 $2,037

Food & beverage: $2,037
CompanyPaymentsAmount
Amgen Inc.9$450
Boehringer Ingelheim Pharmaceuticals, Inc.11$348
AstraZeneca Pharmaceuticals LP4$309
Madrigal Pharmaceuticals8$217
GlaxoSmithKline, LLC.10$165
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$94
Novo Nordisk Inc5$94
Novartis Pharmaceuticals Corporation5$87
PFIZER INC.5$79
Bayer Healthcare Pharmaceuticals Inc.3$64

Products named: OTEZLA, REZDIFFRA, AIRSUPRA, TRELEGY ELLIPTA, JARDIANCE, REPATHA, BREZTRI, OFEV.

Industry payments across NJ — which companies pay providers there.